Immunic Inc. buy Roth Capital
Start price
07.11.25
/
50%
€0.60
Target price
07.11.26
€2.60
Performance (%)
43.81%
Price
27.02.26
€0.86
Summary
This prediction is currently active. The BUY prediction by Roth_Capital for Immunic Inc. has seen massive gains of 43.81%. This prediction currently runs until 07.11.26. The prediction end date can be changed by Roth_Capital at any time. Roth_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Immunic Inc. | 7.635% | 7.635% |
| iShares Core DAX® | -0,38 % | 1,09 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % |
| iShares S&P 500 | -0,71 % | 0,44 % |
Comments by Roth_Capital for this prediction
In the thread Immunic Inc. diskutieren
Immunic (NASDAQ:IMUX) is now covered by analysts at Roth Capital. They set a "buy" rating and a $3.00 price target on the stock.
Ratings data for IMUX provided by MarketBeat